MERTK as a novel therapeutic target in head and neck cancer.
von Mässenhausen A, Sanders C, Thewes B, Deng M, Queisser A, Vogel W, Kristiansen G, Duensing S, Schröck A, Bootz F, Brossart P, Kirfel J, Heasley L, Brägelmann J, Perner S.
von Mässenhausen A, et al. Among authors: deng m.
Oncotarget. 2016 May 31;7(22):32678-94. doi: 10.18632/oncotarget.8724.
Oncotarget. 2016.
PMID: 27081701
Free PMC article.